Literature DB >> 26584810

Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question.

Mario Pacilio1, Roberto Minutolo1, Carlo Garofalo1, Maria Elena Liberti1, Giuseppe Conte1, Luca De Nicola2.   

Abstract

Appropriate timing of starting chronic dialysis in patients with advanced chronic kidney disease (CKD) under nephrology care still is undefined. We systematically reviewed the most recent studies that have compared outcomes of stage 5-CKD under conservative versus substitutive treatment. Eleven studies, most in elderly patients, were identified. Results indicate no advantage of dialysis over conservative management in terms of survival, hospitalization or quality of life. This information is integrated with a case report on a middle-aged CKD patient followed in our clinic who has remained for 15 years in stage 5 despite severe disease. The patient is a diabetic woman who underwent right nephrectomy in 1994 because of renal tuberculosis. In 1999, she commenced regular nephrology care in our clinic and, since 2000, when she was 53 years old, her estimated glomerular filtration rate (eGFR) has been ≤15 ml/min/1.73 m(2). Over the last decade, despite, several episodes of acute kidney injury and placement of permanent percutaneous nephrostomy in 2001, renal function has remained remarkably stable, though severely impaired (eGFR 7.7-5.6 ml/min/1.73 m(2)). Our systematic analysis of the literature and this case report highlight the need for further studies, not limited exclusively to elderly patients, to verify the efficacy of non-dialysis treatment in stage 5-CKD patients. Meanwhile, nephrologists may consider that their intervention can safely prolong for several years the dialysis-free condition in ESRD independently of age.

Entities:  

Keywords:  CKD; Case report; Diabetic kidney disease; Nephrology care; Proteinuria; Systematic review

Mesh:

Year:  2015        PMID: 26584810     DOI: 10.1007/s40620-015-0243-8

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  49 in total

1.  Acute renal failure of unknown origin. Don't forget renal tuberculosis.

Authors:  G Conte; M Iavarone; V Santorelli; L De Nicola
Journal:  Nephrol Dial Transplant       Date:  1997-06       Impact factor: 5.992

2.  Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

Authors:  Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador
Journal:  Kidney Int       Date:  2015-04-29       Impact factor: 10.612

3.  Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease.

Authors:  Marie Evans; Karlijn J van Stralen; Staffan Schön; Karl-Göran Prütz; Maria Stendahl; Bengt Rippe; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2013-07-30       Impact factor: 5.992

4.  Timing of Initiation of RRT and Modality Selection.

Authors:  Joanne M Bargman
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-11       Impact factor: 8.237

5.  Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact.

Authors:  Lucia Di Micco; Serena Torraca; Andrea Pota; Daniela Di Giuseppe; Antonio Pisani; Letizia Spinelli; Simona De Portu; Massimo Sabbatini; Lorenzo Mantovani; Bruno Cianciaruso
Journal:  Nephrol Dial Transplant       Date:  2009-06-16       Impact factor: 5.992

6.  Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists.

Authors:  Moniek W M van de Luijtgaarden; Marlies Noordzij; Charles Tomson; Cécile Couchoud; Giovanni Cancarini; David Ansell; Willem-Jan W Bos; Friedo W Dekker; Jose L Gorriz; Christos Iatrou; Liliana Garneata; Christoph Wanner; Svjetlana Cala; Olivera Stojceva-Taneva; Patrik Finne; Vianda S Stel; Wim van Biesen; Kitty J Jager
Journal:  Am J Kidney Dis       Date:  2012-08-23       Impact factor: 8.860

7.  Outcomes in older adults with stage 5 chronic kidney disease: comparison of peritoneal dialysis and conservative management.

Authors:  Chun Keung Shum; Kui Fu Tam; Wai Leung Chak; Tuen Ching Chan; Ying Fai Mak; Ka Foon Chau
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

8.  Trajectory of quality of life for poor prognosis stage 5D chronic kidney disease with and without dialysis.

Authors:  Ying-Ying Seow; Yin Bun Cheung; Li Min Qu; Alethea Chung Pheng Yee
Journal:  Am J Nephrol       Date:  2013-03-02       Impact factor: 3.754

9.  Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy.

Authors:  Shahid M Chandna; Maria Da Silva-Gane; Catherine Marshall; Paul Warwicker; Roger N Greenwood; Ken Farrington
Journal:  Nephrol Dial Transplant       Date:  2010-11-22       Impact factor: 5.992

10.  The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study.

Authors:  Chia-Jen Shih; Yung-Tai Chen; Shuo-Ming Ou; Wu-Chang Yang; Shu-Chen Kuo; Der-Cherng Tarng
Journal:  BMC Med       Date:  2014-10-06       Impact factor: 8.775

View more
  8 in total

1.  Recommendations for the Care of Patients Receiving Conservative Kidney Management: Focus on Management of CKD and Symptoms.

Authors:  Sara N Davison; Beth Tupala; Betty Ann Wasylynuk; Valerie Siu; Aynharan Sinnarajah; Jean Triscott
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-28       Impact factor: 8.237

2.  Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD.

Authors:  Manjula Kurella Tamura; Manisha Desai; Kristopher I Kapphahn; I-Chun Thomas; Steven M Asch; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2018-05-22       Impact factor: 10.121

3.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

4.  Discussing Conservative Management With Older Patients With CKD: An Interview Study of Nephrologists.

Authors:  Keren Ladin; Renuka Pandya; Allison Kannam; Rohini Loke; Tira Oskoui; Ronald D Perrone; Klemens B Meyer; Daniel E Weiner; John B Wong
Journal:  Am J Kidney Dis       Date:  2018-02-01       Impact factor: 8.860

Review 5.  Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.

Authors:  Vincenzo Bellizzi; Giuseppe Conte; Silvio Borrelli; Adamasco Cupisti; Luca De Nicola; Biagio R Di Iorio; Gianfranca Cabiddu; Marcora Mandreoli; Ernesto Paoletti; Giorgina B Piccoli; Giuseppe Quintaliani; Maura Ravera; Domenico Santoro; Serena Torraca; Roberto Minutolo
Journal:  J Nephrol       Date:  2016-08-27       Impact factor: 3.902

6.  Dialysis timing may be deferred toward very late initiation: An observational study.

Authors:  Yun-Lun Chang; Jie-Sian Wang; Hung-Chieh Yeh; I-Wen Ting; Han-Chun Huang; Hsiu-Yin Chiang; Chiung-Tzu Hsiao; Pei-Lun Chu; Chin-Chi Kuo
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

Review 7.  Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice.

Authors:  Luca De Nicola; Luca Di Lullo; Ernesto Paoletti; Adamasco Cupisti; Stefano Bianchi
Journal:  J Nephrol       Date:  2018-06-07       Impact factor: 3.902

8.  Quality of life, symptoms, and sleep quality of elderly with end-stage renal disease receiving conservative management: a systematic review.

Authors:  Qingli Ren; Qifang Shi; Tong Ma; Jing Wang; Qian Li; Xiaomei Li
Journal:  Health Qual Life Outcomes       Date:  2019-05-03       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.